ABT737 reverses cisplatin resistance by regulating ER-mitochondria Ca2+ signal transduction in human ovarian cancer cells.
第一作者:
Qi,Xie
第一单位:
Department of Pathophysiology, Basic College of Medicine, Jilin University, Changchun, Jilin 130021, P.R. China.
作者:
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);联苯化合物(Biphenyl Compounds);钙(Calcium);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);顺铂(Cisplatin);胞质溶胶(Cytosol);抗药性, 肿瘤(Drug Resistance, Neoplasm);内质网(Endoplasmic Reticulum);女(雌)性(Female);人类(Humans);膜电位, 线粒体(Membrane Potential, Mitochondrial);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);线粒体(Mitochondria);肿瘤移植(Neoplasm Transplantation);硝基酚类(Nitrophenols);卵巢肿瘤(Ovarian Neoplasms);哌嗪类(Piperazines);原癌基因蛋白质c-bcl-2(Proto-Oncogene Proteins c-bcl-2);RNA干扰(RNA Interference);RNA, 小分子干扰(RNA, Small Interfering);信号传导(Signal Transduction);磺胺类(Sulfonamides)
DOI
10.3892/ijo.2016.3733
PMID
27748803
发布时间
2017-06-22
- 浏览8

International journal of oncology
2507-2519页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文